Is Archer Aviation a Buy, Sell or Hold?
Vertical takeoff and landing (eVTOL) aircraft sound futuristic but that’s…
Buy
63
NUTX Quote, Financials, Valuation and Earnings
Last price:
$103.97
Seasonality move
:
-24.22%
Day range:
$78.00 - $84.94
52-week range:
$4.16 - $84.94
Dividend yield:
0%
P/E ratio:
9.20x
P/S ratio:
0.95x
P/B ratio:
3.21x
Volume:
158.5K
Avg. volume:
65.4K
1-year change:
643.14%
Market cap:
$469.6M
Revenue:
$479.9M
EPS (TTM):
-$10.79
Analysts' Opinion
-
Consensus RatingNutex Health has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $78.00, Nutex Health has an estimated downside of -8.17% from its current price of $84.94.
-
Price Target UpsideAccording to analysts, the highest upside price target is $100.00 representing 17.73% upside increase from its current price of $84.94.
Fair Value
-
According to the consensus of 2 analysts, Nutex Health has -8.17% downside to fair value with a price target of $78.00 per share.
NUTX vs. S&P 500
-
Over the past 5 trading days, Nutex Health has overperformed the S&P 500 by 28.84% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Nutex Health does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nutex Health has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Nutex Health reported revenues of $78.8M.
Earnings Growth
-
Nutex Health has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Nutex Health reported earnings per share of -$1.72.
Enterprise value:
522M
EV / Invested capital:
--
Price / LTM sales:
0.95x
EV / EBIT:
4.03x
EV / Revenue:
1.09x
PEG ratio (5yr expected):
--
EV / Free cash flow:
25.03x
Price / Operating cash flow:
21.83x
Enterprise value / EBITDA:
3.51x
Gross Profit (TTM):
$67.8M
Return On Assets:
-9.6%
Net Income Margin (TTM):
-14.09%
Return On Equity:
-48.3%
Return On Invested Capital:
-32.79%
Operating Margin:
12.8%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $219.3M | $247.6M | $479.9M | $69.7M | $257.6M | |
| Gross Profit | $15.4M | $34.8M | $196.3M | $13.2M | $141.6M | |
| Operating Income | -$4.6M | -$1.5M | $137.7M | $4.1M | $114.2M | |
| EBITDA | -$394M | -$14.6M | $148.7M | -$21.8M | $118.9M | |
| Diluted EPS | -$95.50 | -$10.74 | $9.23 | -$7.50 | $11.12 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $135.5M | $154M | $98M | $90.8M | $292.5M | |
| Total Assets | $308.6M | $394.7M | $431.8M | $398.2M | $655.3M | |
| Current Liabilities | $31.5M | $37.7M | $54.9M | $58.3M | $140.9M | |
| Total Liabilities | $161.2M | $203.1M | $311.4M | $319.1M | $453.4M | |
| Total Equity | $147.4M | $191.6M | $120.3M | $79.1M | $201.9M | |
| Total Debt | $100.5M | $89.1M | $38.2M | $40.5M | $40.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $50.6M | $1.3M | $23.2M | -$1.8M | $53.5K | |
| Cash From Investing | -$4.3M | -$11.2M | -$2.7M | $865.6K | -$395.3K | |
| Cash From Financing | -$48.1M | -$2.3M | $1.1M | -$3.9M | -$3M | |
| Free Cash Flow | $36M | -$8.2M | $20.8M | -$950.6K | -$341.8K | |
NUTX
Sector
Market Cap
$469.6M
$33.1M
Price % of 52-Week High
100%
38.72%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.03%
1-Year Price Total Return
643.14%
-49.46%
Beta (5-Year)
0.269
0.743
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
-11.03%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$68.57
200-day SMA
Buy
Level
$30.79
Bollinger Bands (100)
Buy
Level
32.03 - 58.23
Chaikin Money Flow
Sell
Level
-102.4M
20-day SMA
Buy
Level
$60.00
Relative Strength Index (RSI14)
Buy
Level
70.92
ADX Line
Buy
Level
24.61
Williams %R
Sell
Level
0
50-day SMA
Buy
Level
$56.12
MACD (12, 26)
Buy
Level
6.61
25-day Aroon Oscillator
Buy
Level
84
On Balance Volume
Neutral
Level
234.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.1317)
Sell
CA Score
(Annual)
Level (-0.3877)
Sell
Beneish M-Score
(Annual)
Level (-0.7836)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-0.0343)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (3)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
Stock Forecast FAQ
In the current month, NUTX has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NUTX average analyst price target in the past 3 months is $78.00.
-
Where Will Nutex Health Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nutex Health share price will drop to $78.00 per share over the next 12 months.
-
What Do Analysts Say About Nutex Health?
Analysts are divided on their view about Nutex Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nutex Health is a Sell and believe this share price will rise from its current level to $56.00.
-
What Is Nutex Health's Price Target?
The price target for Nutex Health over the next 1-year time period is forecast to be $78.00 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NUTX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nutex Health is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NUTX?
You can purchase shares of Nutex Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nutex Health shares.
-
What Is The Nutex Health Share Price Today?
Nutex Health was last trading at $103.97 per share. This represents the most recent stock quote for Nutex Health. Yesterday, Nutex Health closed at $84.94 per share.
-
How To Buy Nutex Health Stock Online?
In order to purchase Nutex Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Down 50%, Is Dell Technologies a Buy?
Dell (NYSE:DELL)’s share price has been on a roller coaster…
How Bad Will the Stock Market Get?
In recent trading days, global stock markets have seen massive…
Stock Ideas
Sell
36
Is MSFT Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 30x
Sell
30
Is AAPL Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 28x
Sell
33
Is NVDA Stock a Buy?
Market Cap: $2.3T
P/E Ratio: 33x
Alerts
Buy
55
SLNO alert for Apr 9
Soleno Therapeutics [SLNO] is up 7.3% over the past day.
Sell
20
HELE alert for Apr 9
Helen Of Troy [HELE] is up 10.1% over the past day.
Sell
18
OXM alert for Apr 9
Oxford Industries [OXM] is up 17.72% over the past day.
